Observational
Highlights a gap in peri-operative medication management and a lack of clear guidance from pharmaceutical manufacturers regarding drug withdrawal and anesthetic interactions.
Answers are grounded in this paper and cite their sources.
Peri-operative medication review merits attention; cross-sectional data leaves open whether clearer manufacturer guidance reduces risks.
Many patients admitted for surgery are receiving regular drug therapy. Adverse effects may occur, either as a result of these drugs being stopped suddenly or because staff are unaware of significant interactions between certain drugs and anaesthetic agents or techniques. This study aimed to find out how regular drug medication is actually given in the peri-operative period. In addition, pharmaceutical companies were contacted and asked for information about the effects of sudden withdrawal of their products and potential interactions with anaesthetic agents. We found that many drugs were omitted peri-operatively with potentially significant effects. Pharmaceutical companies do not seem to appreciate the importance of this problem and not all of them give clear recommendations relevant to practising anaesthetists.
No takes yet. Share an insight, caveat, or question.
Kluger et al. (1991) conducted an observational in Patients admitted for surgery receiving regular drug therapy. Peri-operative drug prescribing pattern was evaluated on Omission of drugs peri-operatively and pharmaceutical company recommendations.
Synapse has enriched 10 related papers. Consider them for comparative context: